admin

About admin

This author has not yet filled in any details.
So far admin has created 9 blog entries.

AffyImmune Therapeutics Announces First Patient Enrolled in Phase I Clinical Trial of AIC100 CAR T cells for the Treatment of Advanced, Refractory Thyroid Cancer

Natick, MA, October 29, 2020—AffyImmune Therapeutics today announced enrollment of the first patient in its Phase I clinical study evaluating AIC100, the company’s novel affinity-tuned CAR-T cell product, in patients with advanced, refractory thyroid cancer. The trial is designed to test safety, biological activity and real-time assessment of CAR T cell [...]

2020-10-29T19:31:56+00:00October 29th, 2020|

SCIENTIST

AffyImmune Therapeutics (“Affy”), a clinical stage biotechnology company focused on developing technologies that expand the utility and improve the safety and efficacy of cell-based immunotherapy for cancer, is seeking a Scientist to help advance the use of CAR T therapy for solid tumors. As part of the non-clinical team, you will [...]

2020-10-15T14:45:31+00:00October 15th, 2020|

Research Associate

AffyImmune Therapeutics (“Affy”), a development stage biotechnology company focused on creating technologies that expand the utility and improve the safety of cell-based immunotherapy for cancer, is seeking a Research Associate to perform experiments, organize and analyze results, and communicate effectively. As a Research Associate, you will join a small team at [...]

2020-10-15T14:42:48+00:00September 22nd, 2020|